Total Valuation
KUKJE PHARMA Co., Ltd. has a market cap or net worth of ₩65.47B. The enterprise value is ₩85.92K.
Market Cap₩65.47B
Enterprise Value₩85.92K
Share Statistics
KUKJE PHARMA Co., Ltd. has 21,159,832 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding21,159,832
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
KUKJE PHARMA Co., Ltd.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 3.45%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)3.45%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee645.21M
Profits Per Employee20.95M
Employee Count272
Asset Turnover0.92
Inventory Turnover3.19
Valuation Ratios
The current PE Ratio of KUKJE PHARMA Co., Ltd. is 13.4. KUKJE PHARMA Co., Ltd.’s PEG ratio is 1.65.
PE Ratio13.4
PS Ratio0.50
PB Ratio0.90
Price to Fair Value0.90
Price to FCF39.55
Price to Operating Cash Flow10.17
PEG Ratio1.65
Income Statement
In the last 12 months, KUKJE PHARMA Co., Ltd. had revenue of 175.50B and earned 5.70B in profits. Earnings per share was 279.51.
Revenue175.50B
Gross Profit92.97B
Operating Income6.18B
Pretax Income6.44B
Net Income5.70B
EBITDA9.41B
Earnings Per Share (EPS)279.51
Cash Flow
In the last 12 months, operating cash flow was 6.69B and capital expenditures -4.37B, giving a free cash flow of 2.32B billion.
Operating Cash Flow6.69B
Free Cash Flow2.32B
Free Cash Flow per Share109.87
Dividends & Yields
KUKJE PHARMA Co., Ltd. pays an annual dividend of ₩30, resulting in a dividend yield of ―
Dividend Per Share₩30
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.03
52-Week Price Change-32.04%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)57.87K
Important Dates
KUKJE PHARMA Co., Ltd. upcoming earnings date is Nov 12, 2026, TBA (Confirmed).
Last Earnings DateAug 14, 2026
Next Earnings DateNov 12, 2026
Ex-Dividend Date―
Financial Position
KUKJE PHARMA Co., Ltd. as a current ratio of 1.09, with Debt / Equity ratio of 31.59%
Current Ratio1.09
Quick Ratio0.67
Debt to Market Cap0.34
Net Debt to EBITDA2.09
Interest Coverage Ratio6.81
Taxes
In the past 12 months, KUKJE PHARMA Co., Ltd. has paid 738.54M in taxes.
Income Tax738.54M
Effective Tax Rate0.11
Enterprise Valuation
KUKJE PHARMA Co., Ltd. EV to EBITDA ratio is 11.41, with an EV/FCF ratio of 48.44.
EV to Sales0.61
EV to EBITDA11.41
EV to Free Cash Flow48.44
EV to Operating Cash Flow18.40
Balance Sheet
KUKJE PHARMA Co., Ltd. has ₩15.72B in cash and marketable securities with ₩31.39B in debt, giving a net cash position of -₩15.67B billion.
Cash & Marketable Securities₩15.72B
Total Debt₩31.39B
Net Cash-₩15.67B
Net Cash Per Share-₩740.33
Tangible Book Value Per Share₩4.72K
Margins
Gross margin is 53.46%, with operating margin of 3.52%, and net profit margin of 3.25%.
Gross Margin53.46%
Operating Margin3.52%
Pretax Margin3.67%
Net Profit Margin3.25%
EBITDA Margin5.36%
EBIT Margin3.52%
Analyst Forecast
The average price target for KUKJE PHARMA Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast8.02%
EPS Growth Forecast-23.36%